RAD51C and breast cancer: The estimated cumulative risks of developing tubo-ovarian carcinoma (TOC) and breast cancer (BC) at 80 years of age were 11% (95% CI:6–21%) and 21% (95% CI:15–29%) for RAD51C, respectively [4].